Plné znění - 32021R0383

X.

Xxxxx

Xxxxx ES/jiné xxxxx

Xxxxx XXX

Xxxxx ES

Klasifikace/jiné xxxxxxxxxx

1.

1-xxxxx-2,3-xxxxxxxxxxx

xxxxxxxxxxxxxx; 2,3-xxxxxxxxxxx-xxxxxxx

106-89-8

203-439-8

xxxxxxxxxxxx kat. 1B

2.

1,2-dichlorethan

1,2-dichlorethan;

ethan, 1,2-xxxxxxx-

107-06-2

203-458-1

xxxxxxxxxxxx xxx. 1X

3.

2-xxxxxxxxxxxxx

2-xxxxxxxxxxxxx;

xxxxxxx, 2-xxxxxx-

110-80-5

203-804-1

xxxxxxx pro reprodukci xxx. 1B

4.

2-ethoxyethyl-acetát

2-ethoxyethanol-acetát; ethanol, 2-xxxxxx-, 1-xxxxxx

111-15-9

203-839-2

xxxxxxx pro xxxxxxxxxx xxx. 1B

5.

1-ethylpyrrolidin-2-on

1-ethylpyrrolidin-2-on;

N-ethyl-2-pyrrolidon

2687-91-4

220-250-6

toxické xxx xxxxxxxxxx xxx. 1X

6.

2-xxxxxxxxxxxxxx

2-xxxxxxxxxxxxxx;

xxxxxxx, 2-xxxxxxx-

109-86-4

203-713-7

xxxxxxx pro xxxxxxxxxx xxx. 1X

7.

2-xxxxxxxxxxxx-xxxxxx

2-xxxxxxxxxxxx-xxxxxx;

xxxxxxx, 2-xxxxxxx-, 1-xxxxxx;

2-xxxxxxxxxxxxxx-xxxxxx

110-49-6

203-772-9

xxxxxxx xxx xxxxxxxxxx xxx. 1X

8.

2-xxxxxxxxxxxxx-1-xx

2-xxxxxxxxxxxxx-1-xx;

1-xxxxxxxx, 2-xxxxxxx-

1589-47-5

216-455-5

xxxxxxx xxx xxxxxxxxxx xxx. 1X

9.

1-xxxxxxxxxxxxxxxx-2-xx

1-xxxxxx-2-xxxxxxxxxx;

2-xxxxxxxxxxxx, 1-methyl-

872-50-4

212-828-1

toxické xxx xxxxxxxxxx kat. 1X

10.

2-xxxxxxxxxxx

2-xxxxxxxxxxx;

xxxxxx, 2-xxxxx-

79-46-9

201-209-1

xxxxxxxxxxxx xxx. 1X

11.

xxxxxxxxxx xxxx, xxxxxxxxxxxx

xxxxxxxxxx xxxx, xxxxxxxxxxxx;

xxxxxxxxxxxx xxxx xxxx

61791-26-2

xxxxx nebo xxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxxxx xx lidské xxxxxx xxxx xxxxxxx xxxxxxxxx

12.

xxxxxxxxxx xxxx, xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx

xxxxxxxxxx xxxx, ethoxylované x&xxxx;xxxxxxxxxxxxx;

xxxxxxxxxxxx a propoxylovaný amin xxxx

68213-26-3

xxxxx xxxx xxxxxxxxx xxxxx související x&xxxx;xxxxxxxxxxxxx xxxxxx xx xxxxxx xxxxxx xxxx xxxxxxx xxxxxxxxx

13.

xxxxxxxxx vlákna

aktinolitový azbest;

azbest, xxxxxxxxxxxx

77536-66-4

xxxxxxxxxxxx xxx. 1&xxxx;X

14.

xxxxxxxxx xxxxxx;

xxxxxx, xxxxxxxxx

12172-73-5

xxxxxxxxxxxx xxx. 1&xxxx;X

15.

xxxxxxxxxxxx xxxxxx;

xxxxxx, antofylitový

77536-67-5

karcinogenní xxx. 1&xxxx;X

16.

xxxxxxxxxxxx azbest;

azbest, xxxxxxxxxxxx

12001-29-5

xxxxxxxxxxxx xxx. 1 A

17.

krocidolitový xxxxxx;

xxxxxx, krocidolitový

12001-28-4

karcinogenní xxx. 1&xxxx;X

18.

xxxxxxxxxxx azbest;

azbest, tremolitový

77536-68-6

karcinogenní xxx. 1&xxxx;X

19.

xxxxxx

xxxxxx

71-43-2

200-753-7

xxxxxxxxxxxx kat. 1&xxxx;X/

xxxxxxxxx kat. 1X

20.

xxxxx[xxx]xxxxxxx&xxxx;&xxxx;(2);

xxxxx[xxx]xxxxxxxx

xxxxx[xxx]xxxxxxx;

xxxxx[x]xxxxx

50-32-8

200-028-5

xxxxxxxxxxxx xxx. 1X/xxxxxxxxx xxx. 1X/

xxxxxxx xxx reprodukci xxx. 1X

21.

xxx(2-xxxxxxxxxxxx)xxxxxx-1,2-xxxxxxxxxxxx

xxxxxxxxxx-xxxxxx

84-69-5

201-553-2

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxx xxxxxx), toxické xxx xxxxxxxxxx kat. 1X

22.

xxxxxxxx xxxxxx

xxxxxxxx xxxxxx

10043-35-3

11113-50-1

233-139-2

234-343-4

xxxxxxx xxx xxxxxxxxxx xxx. 1X

23.

xxxxxxxxxxx disodný

oktaboritan xxxxxxx; xxxxxxxxxxx disodný, xxxxxxx

12008-41-2

234-541-0

xxxxxxx xxx xxxxxxxxxx xxx. 1X

24.

xxxxxxxxxxx xxxxxxx, tetrahydrát

kyselina xxxxxx, xxxxxxx xxx, xxxxxxxxxxx

12280-03-4

234-541-0

xxxxxxx xxx reprodukci xxx. 1X

25.

xxxxxxxxxxxx xxxxxxx, xxxxxxx

xxxxxxxxxxxx xxxxxxx, bezvodý;

borum-natrium-oxid

1330-43-4

215-540-4

toxické xxx reprodukci kat. 1X

26.

xxxxxxxxxxxx xxxxxxx, xxxxxxxxxx

xxxxx

1303-96-4

215-540-4

xxxxxxx xxx xxxxxxxxxx xxx. 1X

27.

xxxxxxxxxxxx disodný, pentahydrát

borum-natrium-oxid, xxxxxxxxxxx

12179-04-3

215-540-4

xxxxxxx xxx xxxxxxxxxx xxx. 1X

28.

xxxxxxxx orthoboritá, xxxxx sůl

kyselina orthoboritá, xxxxx xxx; kyselina xxxxxx, sodná xxx

13840-56-7

237-560-2

xxxxxxx xxx xxxxxxxxxx kat. 1X

29.

xxxxxxxxxxxx xxxxxxx, xxxxxxxxxx

xxxxxxxxxxxx xxxxxxx, xxxxxxxxxx;

xxxxx-xxxxxxx-xxxx, monohydrát

12267-73-1

235-541-3

toxické xxx xxxxxxxxxx xxx. 1X

30.

xxxx-1,3-xxxx

xxxx-1,3-xxxx;

1,3-xxxxxxxx

106-99-0

203-450-8

xxxxxxxxxxxx xxx. 1&xxxx;X/

xxxxxxxxx xxx. 1X

31.

xxxxx

xxxxxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxxxx (x.&xxxx;XX 203-450-8)

xxxxx

106-97-8

203-448-7

xxxxxxxxxxxx xxx. 1&xxxx;X

32.

xxxxxx(xxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxx-xxxxxxxxxxxx), (xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxx-xxxxxxxxxxxx)

xxxxxxxx, X,X“’-1,6-xxxxxxxxxxxx[X’-xxxxx-, xxxxxxx s 1,6-hexandiaminem, xxxxxxxxxxxx;

xxxx[xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx-1,6-xxxxxxxxx], xxxxxxxxxxxx;

xxxxxxxx, N-kyano-, xxxxx. x&xxxx;1,6-xxxxxxxxxxxxx (2:1), xxxxxxx x&xxxx;1,6-xxxxxxxxxxxxx, xxxxxxxxxxxx (1:2);

XXXX

27083-27-8

x

32289-58-0

x

1802181-67-4

xxxxxxxxxxx xxx xxxxxxx v biocidních xxxxxxxxxxx typu 6 (xxxxxxxxxxx pro xxxxxxx x&xxxx;xxxxxxxxxx obalech)

33.

dibutyl-ftalát

n-butyl-ftalát;

dibutyl-benzen-1,2-dikarboxylát

84-74-2

201-557-4

vlastnosti vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxx xxxxxx), xxxxxxx xxx xxxxxxxxxx xxx. 1X

34.

xxxxxxxxx (xxxxx), xxxxxxxxxxxxx xxxxx naftenické x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (stanovení xxxxxxxx XX 346)

64742-52-5

265-155-0

xxxxxxxxxxxx kat. 1X

35.

xxxxxxxxx (ropné), xxxxxxxxxxxxx xxxxx parafinické x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346)

64742-54-7

265-157-1

xxxxxxxxxxxx xxx. 1X

36.

xxxxxxxxx (xxxxx), hydrogenované xxxxx xxxxxxxxxx s obsahem ≥&xxxx;3,0&xxxx;% hmotnostních xxxxx xxxxxxxxxxxxxxxx do xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346)

64742-53-6

265-156-6

xxxxxxxxxxxx xxx. 1X

37.

xxxxxxxxx (xxxxx), xxxxxxxxxxxxx xxxxx xxxxxxxxxxx s obsahem ≥&xxxx;3,0&xxxx;% hmotnostních xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (stanovení postupem XX 346)

64742-55-8

265-158-7

karcinogenní kat. 1X

38.

xxxxxxxxx (ropné), rozpouštědlově xxxxxxxxxxxxxx xxxxx parafinické x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% hmotnostních xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (stanovení xxxxxxxx XX 346)

64742-65-0

265-169-7

karcinogenní xxx. 1X

39.

xxxxxxxxx (ropné), xxxxxxxxxxxxxx rafinované těžké xxxxxxxxxxx s obsahem ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346)

64741-88-4

265-090-8

xxxxxxxxxxxx xxx. 1X

40.

xxxxxxxxx (xxxxx), xxxxxxxxxxxxxx rafinované xxxxx parafinické x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% hmotnostních xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346)

64741-89-5

265-091-3

xxxxxxxxxxxx xxx. 1X

41.

xxxxxxxxxxx

xxxxxxxxxxx; oxiran; xxxxxxxxxx

75-21-8

200-849-9

xxxxxxxxxxxx xxx. 1X/

xxxxxxxxx xxx. 1X

42.

xxxxxxxxxxx

xxxxxxxxxxx; formalin; xxxxxxxx; xxxxxx

50-00-0

200-001-8

xxxxxxxxxxxx kat. 1B

43.

formamid

formamid; xxxxxxxxxx

75-12-7

200-842-0

xxxxxxx xxx reprodukci xxx. 1B

44.

isobutan (obsahující ≥&xxxx;0,1&xxxx;% xxxxxxxxx (č. ES 203-450-8))

xxxxxxxx; xxxxxx, 2-methyl-

75-28-5

200-857-2

karcinogenní xxx. 1&xxxx;X/

xxxxxxxxx xxx. 1X

45.

xxxxxx oleje (xxxxx), X20–50, xxxxxxxxxxxxx neutrální xxxxx, xxxxxxxxxxxxxx x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% hmotnostních látek xxxxxxxxxxxxxxxx xx dimethylsulfoxidu (XXXX) (xxxxxxxxx xxxxxxxx XX 346)

72623-85-9

276-736-3

xxxxxxxxxxxx kat. 1X

46.

xxxxxx xxxxx (ropné), X15–30, hydrogenované xxxxxxxxx xxxxx, x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (DMSO) (xxxxxxxxx postupem XX 346)

72623-86-0

276-737-9

xxxxxxxxxxxx xxx. 1B

47.

mazací xxxxx (xxxxx), X20–50, xxxxxxxxxxxxx xxxxxxxxx xxxxx, x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% hmotnostních xxxxx extrahovatelných xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx IP 346)

72623-87-1

276-738-4

xxxxxxxxxxxx xxx. 1X

48.

xxxxxx oleje (xxxxx), X17–32, xxxxxxxxxxxxxx xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxxxx, x&xxxx;xxxxxxx ≥ 3,0 % xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx do xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx IP 346)

101316-70-5

309-875-6

xxxxxxxxxxxx xxx. 1X

49.

xxxxxxxxx xxxxxx (xxxxx), xxxxx xxxxxxx, xxxxxxxx xxxxxxxxxx xxxxxxx X9–X12, s obsahem ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7)

64741-65-7

265-067-2

xxxxxxxxxxxx xxx. 1B/

mutagenní kat. 1X

50.

xxxxxxxxx xxxxxx (ropná), xxxxxxxxxxxx odsířená těžká, xxxxxxxx C7–C12, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7)

64742-82-1

265-185-4

xxxxxxxxxxxx xxx. 1&xxxx;X/

xxxxxxxxx xxx. 1X

51.

xxxxxxxxx xxxxxx (xxxxx), hydrogenačně xxxxxxxx xxxxx, xxxxxxxxxxxxxxx, převážně x&xxxx;xxxxxxxx a cykloparafinů X7, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7)

92045-53-9

295-434-2

xxxxxxxxxxxx xxx. 1&xxxx;X/

xxxxxxxxx xxx. 1X

52.

xxxxxxxxx xxxxxx (xxxxx), hydrogenovaná xxxxx, xxxxxxxx X6–X13, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7)

64742-48-9

265-150-3

karcinogenní kat. 1&xxxx;X/

xxxxxxxxx xxx. 1B

53.

benzínová xxxxxx (xxxxx), xxxxx xxxxxxxxxx, xxxxxxxx X8–X10, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7)

64742-95-6

265-199-0

karcinogenní kat. 1&xxxx;X/

xxxxxxxxx xxx. 1X

54.

xxxxxxxxxxx

xxxxxxxxxxx;

xxxxxx, xxxxx-

98-95-3

202-716-0

xxxxxxx xxx xxxxxxxxxx xxx. 1X

55.

X-xxxxxxxxxxxxxx

X-xxxxxxxxxxxxxx; formamid, X-xxxxxx-

123-39-7

204-624-6

xxxxxxx xxx xxxxxxxxxx xxx. 1X

56.

xxxxxxxxxxx:

xxxxx s lineárním x/xxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx s počtem 9 xxxxxx kovalentně vázaných x&xxxx;xxxxxxx xx jakékoliv xxxxxx, zahrnující rovněž xxxxx, xxxxx xxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxxxx

4-(3,5-xxxxxxxxxxxxxx-3-xx)xxxxx;

xxxxx, 4-(1-xxxxx-1,3-xxxxxxxxxxxxxx)-;

4-(1-xxxxx-1,3-xxxxxxxxxxxxxx)xxxxx

186825-36-5

xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

57.

4-(3,6-xxxxxxxxxxxxxx-3-xx)xxxxx;

xxxxx, 4-(1-ethyl-1,4-dimethylpentyl)-;

4-(1-ethyl-1,4-dimethylpentyl)fenol

142731-63-3

vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

58.

4-(2-xxxxxxxxxxx-2-xx)xxxxx;

x-(1,1-xxxxxxxxxxxxxx)xxxxx;

xxxxx, 4-(1,1-dimethylheptyl)-

30784-30-6

250-339-5

vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx prostředí)

59.

4-(3-methyloktan-3-yl)fenol;

fenol, 4-(1-xxxxx-1-xxxxxxxxxxx)-;

4-(1-xxxxx-1-xxxxxxxxxxx)xxxxx

52427-13-1

257-907-1

xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

60.

4-xxxxxxxxxx

x-xxxxxxxxxx;

xxxxx, 4-xxxxx-

104-40-5

203-199-4

xxxxxxxxxx vyvolávající xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

61.

xxxxxxxxxxxxx

11066-49-2

234-284-4

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

62.

x-xxxxxxxxxxxxx;

xxxxx, 4-xxxxxxxx-

26543-97-5

247-770-6

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx REACH – životní xxxxxxxxx)

63.

xxxxxxxxxx;

xxxxx, xxxxx-

25154-52-3

246-672-0

xxxxxxxxxx vyvolávající narušení xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

64.

xxxxx, 4-(1-xxxxxxxxxxx)-;

x-(1-xxxxxxxxxxx)xxxxx

17404-66-9

241-427-4

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

65.

xxxxx, 4-nonyl-, xxxxxxxxxx

84852-15-3

284-325-5

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

66.

xxxxx, nonyl-, xxxxxxxxxx

90481-04-2

291-844-0

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní prostředí)

67.

nonylfenoly, xxxxxxxxxxxx:

xxxxx x&xxxx;xxxxxxxxx x/xxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx x&xxxx;xxxxxx 9 uhlíků xxxxxxxxxx vázaných s fenolem xx jakékoliv xxxxxx, xxxxxxxxxxxx, zahrnující xxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxxx z individuálních xxxxxxx xxxx xxxxxx xxxxxxxxx

xxxxxxxxxx, xxxxxxxxxxxx;

xxxx(xxx-1,2-xxxxxxxxx), α-(nonylfenyl)-ω-hydroxy-

500-024-6

vlastnosti vyvolávající xxxxxxxx endokrinní činnosti (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

68.

4-xxxxxxxxxx, rozvětvený, xxxxxxxxxxxx, 1–2,5 mol;

poly(oxy-1,2-ethandiyl), α-(4-xxxxxxxxxx)-ω-xxxxxxx-, xxxxxxxxxx

500-315-8

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx)

69.

4-xxxxxxxxxx, xxxxxxxxxxxx, 1–2,5 mol

500-045-0

vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí)

70.

2-(2-{2-[2-(4-nonylfenoxy)ethoxy]ethoxy}ethoxy)ethan-1-ol;

2-[2-[2-[2-(4-nonylfenoxy)ethoxy]ethoxy]ethoxy]ethanol;

ethanol, 2-[2-[2-[2-(4-nonylfenoxy)ethoxy]ethoxy]ethoxy]-

7311-27-5

230-770-5

vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

71.

2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxxx;

xxxxxxx, 2-[2-(4-xxxxxxxxxxx)xxxxxx]-

20427-84-3

243-816-4

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – životní xxxxxxxxx)

72.

20-(4-xxxxxxxxxxx)-3,6,9,12,15,18-xxxxxxxxxxxxx-1-xx;

3,6,9,12,15,18-xxxxxxxxxxxxxx-1-xx, 20-(4-xxxxxxxxxxx)-

27942-27-4

248-743-1

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. f) xxxxxxxx REACH – xxxxxxx xxxxxxxxx)

73.

2-[2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]xxxxx-1-xx;

xxxxxxx, 2-[2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]-

7311-27-5

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx)

74.

26-(4-xxxxxxxxxxx)-3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx;

3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx, 26-(4-xxxxxxxxxxx)-

14409-72-4

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

75.

17-(4-xxxxxxxxxxx)-3,6,9,12,15-xxxxxxxxxxxxxxxxxx-1-xx;

3,6,9,12,15-xxxxxxxxxxxxxxxxxx-1-xx, 17-(4-nonylfenoxy)-

34166-38-6

vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

76.

xxxx(xxx-1,2-xxxxxxxxx), α-(4-xxxxxxxxxx)-ω-xxxxxxx-, xxxxxxxxxx

127087-87-0

xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

77.

xxxx(xxx-1,2-xxxxxxxxx), α-(4-xxxxxxxxxx)-ω-xxxxxxx-

26027-38-3

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

78.

xxxxxxx, 2-(4-xxxxxxxxxxx)-

104-35-8

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – životní xxxxxxxxx)

79.

xxxxxxxxxxxxx, xxxxxxxxxxxx;

xxxx(xxx-1,2-xxxxxxxxx), α-(isononylfenyl)-ω-hydroxy-

37205-87-1

vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní činnosti (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx)

80.

2-[2-(4-xxxx-xxxxxxxxxxx)xxxxxx]xxxxxxx;

xxxxxxx, 2-[2-(4-xxxx-xxxxxxxxxxx)xxxxxx]-

156609-10-8

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní prostředí)

81.

poly(oxy-1,2-ethandiyl), α-(xxxxxxxxxx)-ω-xxxxxxx-

xxxxxxxxxx, xxxxxxxxxxxx

9016-45-9

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx)

82.

xxxxxxxxxxx:

xxxxx s lineárním x/xxxx rozvětveným xxxxxxxxx xxxxxxxx x&xxxx;xxxxxx 8 xxxxxx kovalentně vázaných x&xxxx;xxxxxxx xx jakékoliv xxxxxx, zahrnující rovněž xxxxx, které xxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxx xxxx xxxxxx kombinaci

p-oktylfenol;

4-oktylfenol

1806-26-4

217-302-5

vlastnosti xxxxxxxxxxxx narušení endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – životní xxxxxxxxx)

83.

4-(2,4,4-xxxxxxxxxxxxxxx-2-xx)xxxxx;

4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx;

4-(xxxx-xxxxx)xxxxx;

xxxxx, 4-(1,1,3,3-xxxxxxxxxxxxxxxx)-;

4-xxxx-xxxxxxxxxx

140-66-9

205-426-2

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

84.

xxxxxxxxxx;

xxxxx, oktyl-

67554-50-1

266-717-8

vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní činnosti (xx.&xxxx;57 písm. f) xxxxxxxx REACH – xxxxxxx xxxxxxxxx)

85.

xxxxx, 2-xxxxxxxx-

86378-08-7

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení REACH – xxxxxxx xxxxxxxxx)

86.

xxxxx, xxxxxxxx-;

xxxxxxxxxxxxx

11081-15-5

234-304-1

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (čl. 57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx)

87.

xxxxx, 2-xxxxx-;

x-xxxxxxxxxx

949-13-3

213-437-9

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx prostředí)

88.

fenol, 2-xxx-xxxxx-;

x-xxx-xxxxxxxxxx

26401-75-2

247-663-4

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – životní xxxxxxxxx)

89.

xxxxx, 4-xxxxxxxx-;

x-xxxxxxxxxxxxx

27013-89-4

248-164-4

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx)

90.

xxxxx, 4-xxx-xxxxx-;

x-xxx-xxxxxxxxxx

27214-47-7

248-330-6

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

91.

xxxxx, xxx-xxxxx-;

xxx-xxxxxxxxxx

93891-78-2

299-461-0

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – životní xxxxxxxxx)

92.

xxxxx, 4-(1-xxxxxxxxxx)-;

x-(1-xxxxxxxxxx)xxxxx

3307-00-4

221-989-7

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) nařízení XXXXX – životní xxxxxxxxx)

93.

xxxxx, 2-(1-xxxxxxxxxxxxxx)-;

x-(1-xxxxxxxxxxxx)xxxxx

18626-98-7

242-459-1

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

94.

xxxxx, 2-(1-xxxxxxxxxx)-;

x-(1-xxxxxxxxxx)xxxxx

17404-44-3

241-426-9

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – životní xxxxxxxxx)

95.

xxxxx, 2-(1-xxxxxxxxxxxx)-;

x-(1-xxxxxxxxxxxx)xxxxx

37631-10-0

253-574-1

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

96.

xxxxx, 4-(1-xxxxxxxxxxxx)-;

x-(1-xxxxxxxxxxxx)xxxxx

3307-01-5

221-990-2

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx)

97.

xxxxx, 2-(1-xxxxxxxxxxxx)-;

x-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx

3884-95-5

223-420-8

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) nařízení XXXXX – životní prostředí)

98.

fenol, (1,1,3,3-xxxxxxxxxxxxxxxx)-;

(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx

27193-28-8

248-310-7

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

99.

xxxxx, (1-xxxxxxxxxxxx)-;

(1-xxxxxxxxxxxx)xxxxx

27985-70-2

248-759-9

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

100.

xxxxx, 4-(2-xxxxxxxxxxxx)-

898546-19-5

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – životní xxxxxxxxx)

101.

xxxxx, 2-(2-xxxxxxxxxx)-

28752-62-7

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) nařízení XXXXX – životní xxxxxxxxx)

102.

xxxxx, 4-(1-methylheptyl)-;

p-(1-methylheptyl)fenol

1818-08-2

217-332-9

vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx)

103.

xxxxx, 4-(2-ethylhexyl)-

69468-20-8

vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – životní xxxxxxxxx)

104.

xxxxx, 4-(5-xxxxxxxxxxxx)-

1824164-95-5

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – životní xxxxxxxxx)

105.

xxxxx, 2-(2-methylheptyl)-

898546-20-8

vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

106.

xxxxx, 4-(2-xxxxxxxxxxxx)-

119747-99-8

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – životní xxxxxxxxx)

107.

xxxxx, 3-xxxxx-

20056-69-3

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

108.

xxxxx, 2-(1,1-dimethylhexyl)-

1824575-79-2

vlastnosti vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx prostředí)

109.

fenol, 4-(1,1-xxxxxxxxxxxxx)-

30784-29-3

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) nařízení REACH – životní xxxxxxxxx)

110.

xxxxx, 4-(5,5-xxxxxxxxxxxxx)-

13330-52-4

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx)

111.

xxxxx, 2-(5,5-xxxxxxxxxxxxx)-

1822989-97-8

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx prostředí)

112.

fenol, 3-(1,1-xxxxxxxxxxxxx)-

70435-92-6

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí)

113.

fenol, 4-(1,4-xxxxxxxxxxxxx)-

164219-26-5

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. f) xxxxxxxx XXXXX – životní xxxxxxxxx)

114.

xxxxxxxxxxx, ethoxylované:

látky x&xxxx;xxxxxxxxx x/xxxx rozvětveným xxxxxxxxx xxxxxxxx x&xxxx;xxxxxx 8 xxxxxx xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxx xx xxxxxxxxx xxxxxx, xxxxxxxxxxxx, zahrnující xxxxxx látky, které xxxxxxxx xxxxxxxxx z individuálních xxxxxxx nebo xxxxxx xxxxxxxxx

xxxx(xxx-1,2-xxxxxxxxx), α-[(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx]-ω-xxxxxxx-;

2-(2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]xxxxxx)xxxxxxx;

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

9036-19-5

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí)

115.

2-[4-(2,4,4-trimethylpentan-2-yl)fenoxy]ethanol;

poly(oxy-1,2-ethandiyl), α-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx]-ω-xxxxxxx-;

xxxxxxxxxx, xxxxxxxxxxxx

9002-93-1

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. f) nařízení XXXXX – životní xxxxxxxxx)

116.

20-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]-3,6,9,12,15,18-xxxxxxxxxxxxx-1-xx;

3,6,9,12,15,18-xxxxxxxxxxxxxx-1-xx, 20-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]-

2497-59-8

219-682-8

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

117.

xxxxxxx, 2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]-

2315-67-5

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

118.

xxxxxxx, 2-[2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]xxxxxx]-

2315-61-9

xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

119.

3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx, 26-(4-xxxxxxxxxxx)-

42173-90-0

255-695-5

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

120.

xxxx(xxx-1,2-xxxxxxxxx), α-(oktylfenyl)-ω-hydroxy-, xxxxxxxxxx

68987-90-6

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx)

121.

xxxx(xxx-1,2-xxxxxxxxx), α-[4-(6-xxxxxxxxxxxx)xxxxx]-ω-xxxxxxx-

59379-12-3

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

122.

xxxxxxx, 2-(4-xxxxxxxxxxx)-;

2-(x-xxxxxxxxxxx)xxxxxxx

51437-89-9

257-203-4

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx)

123.

xxxx(xxx-1,2-xxxxxxxxx), α-(4-xxxxxxxxxx)-ω-xxxxxxx-

26636-32-8

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx)

124.

xxxx(xxx-1,2-xxxxxxxxx), α-[4-(1-xxxxxxxxxxxx)xxxxx]-ω-xxxxxxx-

73935-42-9

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

125.

3,6,9,12,15,18-xxxxxxxxxxxxxx-1-xx, 20-(4-xxxxxxxxxxx)-;

20-(4-xxxxxxxxxxx)-3,6,9,12,15,18-xxxxxxxxxxxxx-1-xx

32742-88-4

251-190-9

xxxxxxxxxx xxxxxxxxxxxx narušení endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

126.

xxxxxxx, 2-[2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]-;

2-(x-xxxxxxxxxxx)xxxxxxx

51437-92-4

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

127.

xxxxxxx, 2-[2-(4-xxxxxxxxxxx)xxxxxx]-

51437-90-2

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí)

128.

3,6,9,12,15-pentaoxaheptadekan-1-ol, 17-(4-xxxxxxxxxxx)-

51437-94-6

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx)

129.

xxxx(xxx-1,2-xxxxxxxxx), α-(xxxxxxxxxxxxx)-ω-xxxxxxx-

9004-87-9

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

130.

2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxxx

51437-91-3

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

131.

3,6,9,12,15-xxxxxxxxxxxxxxxxxx-1-xx, 17-[4-(1,1,3,3-tetramethylbutyl)fenoxy]-

2497-58-7

vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx prostředí)

132.

ethanol, 2-[2-[2-[4-(1,1,3,3-tetramethylbutyl)fenoxy]ethoxy]ethoxy]-

2315-62-0

vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx)

133.

xxxxxxx, 2-[2-[2-[2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]xxxxxx]-

2315-63-1

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx)

134.

3,6,9,12-xxxxxxxxxxxxxxxxxx-1-xx, 14-[4-(1,1,3,3-tetramethylbutyl)fenoxy]-

2315-64-2

vlastnosti vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 písm. f) xxxxxxxx REACH – xxxxxxx prostředí)

135.

3,6,9,12,15,18,21,24-oktaoxahexakosan-1-ol, 26-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]-

2315-65-3

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – životní prostředí)

136.

3,6,9,12,15,18,21,24,27-nonaoxanonakosan-1-ol, 29-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]-

2315-66-4

xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – životní xxxxxxxxx)

137.

xxxxxxx, 2-[3-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]-

1026254-24-9

xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx)

138.

xxxxxxx, 2-[2-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]-

84658-53-7

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx)

139.

xxxxxxx, 2-[2-(xxxxxxxxxxx)xxxxxx]-

27176-92-7

xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx)

140.

X,X-xxxxxxxxxxxxxxxx

X,X-xxxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxx; DMF

68-12-2

200-679-5

toxické xxx xxxxxxxxxx kat. 1X

141.

xxxx-2-xxxxxx

xxxxxxxxx; 2-xxxxxxxxxx

79-06-1

201-173-7

xxxxxxxxxxxx xxx. 1X/

xxxxxxxxx kat. 1X

142.

xxxxxxx, xxxxxxxxxxxxx, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (č. ES 200-753-7)

68391-11-7

269-929-9

karcinogenní xxx. 1&xxxx;X/

xxxxxxxxx xxx. 1X

143.

xxxxxxxx

xxxxxxxx

91-22-5

202-051-6

xxxxxxxxxxxx xxx. 1X

144.

xxxxxxxxxxxxxxxxxxxxxxxxx

xxxxxxxxxxxxxxxxxxxxxxxxx;

2-xxxxxxxxxxxxx, xxxxxxxxxx-

97-99-4

202-625-6

xxxxxxx pro xxxxxxxxxx xxx. 1X